LMAN2 and breast carcinoma: Next, we explored the link between LMAN2 expression in breast cancer and drug sensitivity using GDSC databases and identified a positive link between the LMAN2 expression and the resistance of breast cancer cells to multiple DNA damage chemotherapeutic drugs, such as cisplatin and mitomycin (p ≤ 0.05) (Figures 7(b) and 7(d)).